Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer

NCT07108309

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Health Institution "Brest Regional Oncology Center" Brest, Belarus
  • "Gomel Regional Clinical Oncology Dispensary" Homyel, Belarus
  • Minsk City Oncology Center Minsk, Belarus
  • State Budgetary Institution of Healthcare of the Arkhangelsk Region "Arkhangelsk Clinical Oncology Dispensary" Arkhangelsk, Russia
View all 47 locations
View Trial Details
Recruiting

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

NCT05862064

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

A Beta-only IL-2 ImmunoTherapY Study

NCT05086692

Conditions
Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
Locations
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Providence Saint John's Health Center Santa Monica, California, United States
  • Boca Raton Regional Hospital Boca Raton, Florida, United States
View all 27 locations
View Trial Details

Related conditions